IRWIN NATURALS LOGO [NEW BRANDING].jpg
Klee Irwin Presenting at Psychedelic Capital
25 mai 2022 11h49 HE | Irwin Naturals
LOS ANGELES, May 25, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that Klee Irwin, CEO, will be presenting at the...
MYCO Logo 2021.jpg
Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules
16 févr. 2022 07h30 HE | Mydecine Innovations Group Inc.
DENVER, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
logo.png
PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights
18 août 2020 08h30 HE | Global Trac Solutions, Inc.
LAS VEGAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that in an effort to accelerate the Company’s...
logo.png
PSYC Interviews Chief Architects and Petitioners of Oregon’s Psilocybin Therapy Initiative
21 juil. 2020 08h30 HE | Global Trac Solutions, Inc.
LAS VEGAS, July 21, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce the release of a special edition of its Microdose...
logo.png
PSYC Expands its Reach with the Launch of Social Media Platforms
16 juil. 2020 08h30 HE | Global Trac Solutions, Inc.
LAS VEGAS, July 16, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company’s new social media channels are...
PLUS™ Unveils New Classic Mints
PLUS™ Unveils New Classic Mints
18 avr. 2019 07h30 HE | Plus Products Inc.
SAN MATEO, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Continuing to demonstrate its passion for providing low-dose cannabis edibles that consumers love, Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)...
EYEN.png
Eyenovia, Inc. announces publication of Phase II study results demonstrating benefits of micro-formulation over conventional eyedroppers and addition of Scientific Advisory Board members
28 nov. 2016 15h46 HE | Eyenovia, Inc
Eyenovia’s study shows that conventional ophthalmic eye drops significantly overdose the eye and that equivalent, or greater, pharmacodynamic effect can be achieved with 80% less ocular exposure...